EV Nickel Inc. | WebDisclosure

PRESS RELEASE

published on 06/04/2024 at 07:30, 1 year 9 months ago

APONTIS PHARMA continues to gear organization towards growth and internationalization – Renowned industry expert leads supply chain management
APONTIS PHARMA appoints renowned industry expert Mila Brückel as Head of Supply Chain, gearing organization towards growth and internationalization

Pharmaceutical Industry Supply Chain Management APONTIS PHARMA Internationalization Mila Brückel
PRESS RELEASE

published on 05/15/2024 at 14:26, 1 year 10 months ago

Original-Research: APONTIS PHARMA AG (von Montega AG): Kaufen
APONTIS PHARMA AG startet mit starker Ergebnisentwicklung in das Geschäftsjahr 2024. Umsatz und EBITDA verbessern sich deutlich laut Analyse von Montega AG

Montega AG Investment APONTIS PHARMA AG Finanzen Ergebnisentwicklung
BRIEF

published on 05/08/2024 at 07:35, 1 year 10 months ago

APONTIS PHARMA Reports Positive Start to FY 2024 with Increase in Single Pill Revenue

Pharmaceutical Industry APONTIS PHARMA Financial Growth Novartis Agreement Single Pill Revenue
BRIEF

published on 05/08/2024 at 07:35, 1 year 10 months ago

APONTIS PHARMA annonce un début positif pour son exercice 2024 avec une augmentation des revenus d'une pilule unique

Croissance Financière Industrie Pharmaceutique PHARMA APONTIS Accord Novartis Revenus D'une Seule Pilule
PRESS RELEASE

published on 05/08/2024 at 07:30, 1 year 10 months ago

APONTIS PHARMA starts financial year 2024 with growth in revenue of Single Pill combinations and positive net result – forecast for full-year 2024 confirmed
APONTIS PHARMA reports growth in revenue of Single Pill combinations and positive net result in Q1 2024, confirming forecast for full-year 2024. Improved EBITDA and new sales model aims to increase revenue further

Revenue Growth Forecast APONTIS PHARMA Single Pill Combinations Q1 2024
BRIEF

published on 04/16/2024 at 13:05, 1 year 11 months ago

EV Nickel Inc. Launches Comprehensive 2024 Exploration Program

Sustainable Mining Clean Energy Nickel Exploration Canadian Mining Mineral Finance
BRIEF

published on 04/16/2024 at 13:05, 1 year 11 months ago

EV Nickel Inc. lance un programme d'exploration complet pour 2024

Énergie Propre Exploitation Minière Durable Exploitation Minière Canadienne Exploration Du Nickel Financement Minier
PRESS RELEASE

published on 04/16/2024 at 13:00, 1 year 11 months ago

EV Nickel Announces Fully Funded Exploration Program
EV Nickel Inc. announces its 2024 exploration program focusing on its significant Nickel deposits in Timmins, Ontario, following a $5.1M financing. The program includes geophysical surveys, metallurgical test work, and diamond drilling

Diamond Drilling 2024 Exploration Program EV Nickel Inc. Nickel Deposits Timmins Ontario
PRESS RELEASE

published on 04/15/2024 at 14:01, 1 year 11 months ago

Original-Research: Apontis Pharma AG (von Montega AG): Kaufen
Montega AG stuft Apontis Pharma AG hoch und aktualisiert das Kursziel auf 16,50 EUR aufgrund neuer Vertriebsstrategie und Kooperation mit Novartis. Analyst Tim Kruse empfiehlt Kauf

Montega AG APONTIS PHARMA AG Kursziel 16,50 EUR Vertriebsstrategie Kooperation Novartis
BRIEF

published on 04/05/2024 at 10:22, 1 year 11 months ago

APONTIS PHARMA Secures Five-Year Distribution and Marketing Deal with Novartis for Asthma Medications

Pharmaceutical Industry Financial Forecast APONTIS PHARMA Asthma Medications Novartis

Published on 03/26/2026 at 22:05, 19 minutes ago

BlackBerry to Announce Fourth Quarter and Fiscal Year 2026 Results on April 9, 2026
Published on 03/26/2026 at 22:00, 24 minutes ago

Clean Air Metals Receives Provincial Funding and Provides Update on the Thunder Bay North Project
Published on 03/26/2026 at 22:00, 24 minutes ago

Green Bridge Metals Reports Visible Copper Sulfide Mineralization in Initial 2026 Titac Drilling, Duluth Complex Minnesota
Published on 03/26/2026 at 21:00, 1 hour 24 minutes ago

Worksport Reports Record FY 2025 Results, Issues $35M–$42M 2026 Revenue Guidance; Targets Initial Cash Flow Positivity
Published on 03/26/2026 at 21:00, 1 hour 24 minutes ago

Rocky Shore Closes Acquisition of Additional Mining Claims

View all ACCESSWIRE

Published on 03/26/2026 at 20:48, 1 hour 36 minutes ago

Dermapharm Holding SE repurchases 4,299,190 shares under its public share buyback offer
Published on 03/26/2026 at 19:20, 3 hours 4 minutes ago

Critical Path Institute Launches 'One to Millions' to Reshape the Future of Individualized Medicine at Global Scale
Published on 03/26/2026 at 19:13, 3 hours 11 minutes ago

Director Declaration
Published on 03/26/2026 at 19:09, 3 hours 14 minutes ago

2CRSi SA: Résultats 1er Semestre 2025/26 : Chiffre d'Affaires 204,7 M€ (x9,8) EBITDA de 9,6 M€ (x4,6)
Published on 03/26/2026 at 19:09, 3 hours 14 minutes ago

2CRSi SA: First Half 2025/26 Results: Revenue of €204.7 million (x9.8) EBITDA of €9.6 million (x4.6)

View all EQS

Published on 03/26/2026 at 18:17, 4 hours 7 minutes ago

Eiffage se renforce au capital de Getlink et porte sa participation à 29,40 % du capital
Published on 03/26/2026 at 18:17, 4 hours 7 minutes ago

Eiffage strengthens its position in Getlink capital
Published on 03/26/2026 at 18:00, 4 hours 24 minutes ago

Arrêté des comptes au 31 décembre 2025 et perspectives 2026
Published on 03/26/2026 at 18:00, 4 hours 24 minutes ago

Calendrier financier 2026
Published on 03/26/2026 at 18:00, 4 hours 24 minutes ago

LABORATOIRES EUROMEDIS - Fin du contrat de liquidité

View all LES ECHOS COMFI WIRE

News